Bone Marrow Transplantation

Top Story

American Cancer Society creates blueprint to reduce cancer mortality by 2035

American Cancer Society creates blueprint to reduce cancer mortality by 2035
July 10, 2018

Ruxolitinib shows promising response rate for graft-versus-host disease

June 22, 2018
A phase 2 trial of ruxolitinib met its primary endpoint of overall response rate for the treatment of patients with steroid-refractory graft-versus-host disease…
In the Journals Plus

Longer donor leukocyte telomere reduces infection-related mortality in aplastic anemia

June 10, 2018
Longer donor leukocyte telomere length appeared associated with reduced infection-related mortality among patients with severe aplastic anemia who underwent…

Should research efforts focus on completely preventing GVHD?

HemOnc Today, June 10, 2018
POINT Transplantation is the only curative treatment for many hematologic diseases; but, at the same time, GVHD is a major morbidity, and mortality of this procedure has been…
More Headlines »

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

Early detection and appropriate management of melanoma is imperative for optimal clinical outcomes. For patients…
More »
Meeting News Coverage

VIDEO: Physicians must wait for STAMINA data to ‘really play out’ for posttransplant myeloma treatment

December 29, 2016
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting


Ace the Case: A 33-Year-Old Woman with a Mass in Her Right Breast

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a breast mass in a…
More »